Recommanded Product: 105-13-5. About (4-Methoxyphenyl)methanol, If you have any questions, you can contact Bolen, SD; Love, TE; Einstadter, D; Lever, J; Lewis, S; Persaud, H; Fiegl, J; Liu, RJ; Ali-Matlock, W; Bar-Shain, D; Caron, A; Misak, J; Wagner, T; Kauffman, E; Cook, L; Hebert, C; White, S; Kobaivanova, N; Cebul, R or concate me.
Recommanded Product: 105-13-5. Authors Bolen, SD; Love, TE; Einstadter, D; Lever, J; Lewis, S; Persaud, H; Fiegl, J; Liu, RJ; Ali-Matlock, W; Bar-Shain, D; Caron, A; Misak, J; Wagner, T; Kauffman, E; Cook, L; Hebert, C; White, S; Kobaivanova, N; Cebul, R in SPRINGER published article about in [Bolen, Shari D.; Love, Thomas E.; Einstadter, Douglas; Lewis, Steven; Bar-Shain, David; Caron, Aleece; Cebul, Randall] Case Western Reserve Univ, Populat Hlth Res Inst, Ctr Hlth Care Res & Policy, MetroHlth Syst, Cleveland, OH 44106 USA; [Bolen, Shari D.; Love, Thomas E.; Einstadter, Douglas; Lever, Jonathan; Ali-Matlock, Wanda; Bar-Shain, David; Cebul, Randall] Better Hlth Partnership, Cleveland, OH USA; [Bolen, Shari D.; Love, Thomas E.; Einstadter, Douglas; Lewis, Steven; Caron, Aleece] Case Western Reserve Univ, Dept Med, MetroHlth Syst, Cleveland, OH 44106 USA; [Bolen, Shari D.; Love, Thomas E.; Einstadter, Douglas; Persaud, Harry; Cebul, Randall] Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Fiegl, Jordan] Univ Hosp, Dept Data Sci & Analyt, Cleveland, OH USA; [Liu, Rujia] Medpace Inc, Cincinnati, OH USA; [Bar-Shain, David] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Misak, James] Case Western Reserve Univ, Dept Family Med, MetroHlth Syst, Cleveland, OH 44106 USA; [Wagner, Todd] Signature Hlth, Mentor, OH USA; [Kauffman, Erick] Neighborhood Family Practice, Cleveland, OH USA; [Cook, Lloyd] Med Mutual, Cleveland, OH USA; [Hebert, Christopher] Mercy Hlth, Cincinnati, OH USA; [Kobaivanova, Nana] Cleveland Clin, Cleveland, OH USA in 2021, Cited 28. The Name is (4-Methoxyphenyl)methanol. Through research, I have a further understanding and discovery of 105-13-5
BACKGROUND: Accelerated translation of real-world interventions for hypertension management is critical to improving cardiovascular outcomes and reducing disparities. OBJECTIVE: To determine whether a positive deviance approach would improve blood pressure (BP) control across diverse health systems. DESIGN: Quality improvement study using 1-year cross sections of electronic health record data over 5 years (2013-2017). PARTICIPANTS: Adults >= 18 with hypertension with two visits in 2 years with at least one primary care visit in the last year (N = 114,950 at baseline) to a primary care practice in Better Health Partnership, a regional health improvement collaborative. INTERVENTIONS: Identification of a positive deviant and dissemination of this system’s best practices for control of hypertension (i.e., accurate/repeat BP measurement; timely follow-up; outreach; standard treatment algorithm; and communication curriculum) using 3 different intensities (low: Learning Collaborative events describing the best practices; moderate: Learning Collaborative events plus consultation when requested; and high: Learning Collaborative events plus practice coaching). MAIN MEASURES: We used a weighted linear model to estimate the pre- to post-intervention average change in BP control (< 140/90 mmHg) for 35 continuously participating clinics. KEY RESULTS: BP control post-intervention improved by 7.6% [95% confidence interval (CI) 6.0-9.1], from 67% in 2013 to 74% in 2017. Subgroups with the greatest absolute improvement in BP control included Medicaid (12.0%, CI 10.5-13.5), Hispanic (10.5%, 95% CI 8.4-12.5), and African American (9.0%, 95% CI 7.7-10.4). Implementation intensity was associated with improvement in BP control (high: 14.9%, 95% CI 0.2-19.5; moderate: 5.2%, 95% CI 0.8-9.5; low: 0.2%, 95% CI-3.9 to 4.3). CONCLUSIONS: Employing a positive deviance approach can accelerate translation of real-world best practices into care across diverse health systems in the context of a regional health improvement collaborative (RHIC). Using this approach within RHICs nationwide could translate to meaningful improvements in cardiovascular morbidity and mortality.
Recommanded Product: 105-13-5. About (4-Methoxyphenyl)methanol, If you have any questions, you can contact Bolen, SD; Love, TE; Einstadter, D; Lever, J; Lewis, S; Persaud, H; Fiegl, J; Liu, RJ; Ali-Matlock, W; Bar-Shain, D; Caron, A; Misak, J; Wagner, T; Kauffman, E; Cook, L; Hebert, C; White, S; Kobaivanova, N; Cebul, R or concate me.
Reference:
Alcohol – Wikipedia,
,Alcohols – Chemistry LibreTexts